Delivery Order SPE2DB25D3306-SPE2DB25FUCNG
- Not listed
- The Defense Logistics Agency (DLA) awarded a $5,734.19 delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 mL pens on October 22, 2025, with an ultimate completion date of October 23, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Trulicity is a diabetes management medication, representing one of many pharmaceutical products AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a $3,863.83 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens with a completion date of September 9, 2025. The contract utilizes a firm fixed-price structure with no set-aside designation, indicating competitive award to the vendor. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location, serving as the company's corporate headquarters and primary...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,000.54 for Trulicity 1.5 mg/0.5 ml pens on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly utilized within military and federal healthcare systems, reflecting...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,096.22 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens on October 27, 2025, with an ultimate completion date of October 28, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,458.30 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed-price delivery order represents a non-competitive award issued under a larger contract vehicle and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. Trulicity is a prescription diabetes medication commonly used within military...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,535.16 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens on August 22, 2025, with completion targeted for August 25, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $6,224.01 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL) on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed price, non-set-aside contract is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,744.44 to AmerisourceBergen Drug Corp for Trulicity 4.5 mg/0.5 ml pens on November 13, 2025, with an ultimate completion date of November 14, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded through an open procurement process. The contract calls for delivery to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. Trulicity is a brand-name diabetes...
- The Defense Logistics Agency awarded a $3,348.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Trulicity 4.5 mg/0.5 ml pens with an ultimate completion date of September 8, 2025. The order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a widely-used injectable diabetes medication, reflecting the company's role as a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on August 13, 2025, valued at $1,201.20 for the supply of Trulicity 3 mg/0.5 ml pens (0.5 ml units). This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 14, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used to...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB25FUCNGDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,099.89 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 6, 2025, with completion expected by August 7, 2025. This firm fixed price contract was competitively awarded without set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Trulicity is a prescription medication used in diabetes management, consistent with AmerisourceBergen's extensive portfolio of pharmaceutical products supplied to federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for federal medical procurement across the Defense Health Agency, U.S. Coast Guard, and military healthcare systems worldwide, supplying a comprehensive range of medications, vaccines, medical devices, and specialized healthcare commodities. The parent IDC enables the company to fulfill diverse federal medical supply requirements through flexible ordering mechanisms supporting military and veteran healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 8/6/25 |